Omeros (OMER) Cash from Financing Activities (2010 - 2026)

Omeros (OMER) reported Cash from Financing Activities of -$22.0 million for Q1 2026, down 1095.32% on a YoY basis from $2.2 million in Q1 2025, and up 65.89% sequentially from -$64.4 million in Q4 2025.

Omeros (OMER) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Omeros (OMER) has 17 years of Cash from Financing Activities data on file, last reported at -$22.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Financing Activities fell 1095.32% year-over-year to -$22.0 million; the trailing twelve-month figure through Mar 2026 stood at -$62.3 million (down 66.66% YoY), and the FY2025 full-year result was -$42.2 million, down 167.06% from the prior year.
  • Cash from Financing Activities advanced to -$22.0 million in Q1 2026, from -$64.4 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $124.8 million in Q3 2022 to a low of -$105.0 million in Q4 2023.
  • A 5-year average of $993764.7 and a median of -$651000.0 in 2022 frame the typical range for Cash from Financing Activities.
  • Across the five-year window, Cash from Financing Activities jumped 26016.53% in 2022 and plunged 16021.81% in 2023, its largest moves.
  • Tracing OMER's Cash from Financing Activities over 5 years: stood at -$651000.0 in 2022, then sank by 16021.81% to -$105.0 million in 2023, then soared by 96.1% to -$4.1 million in 2024, then plunged by 1473.6% to -$64.4 million in 2025, then soared by 65.89% to -$22.0 million in 2026.
  • Business Quant data shows OMER's Cash from Financing Activities at -$22.0 million in Q1 2026, -$64.4 million in Q4 2025, and $25.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 30.14 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 68.63 Mn
4 NuCana 279.75 Bn 279.75 Bn - 9,311.16
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -538.80 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -802.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 238.74 Mn
10 Omeros 739.31 Mn 739.31 Mn 9.31 Mn -21.98 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -21.98 Mn
Mar 31, 2026 -21.98 Mn
Dec 31, 2025 -64.44 Mn
Dec 31, 2025 -64.44 Mn
Sep 30, 2025 25.83 Mn
Sep 30, 2025 25.83 Mn
Jun 30, 2025 -1.72 Mn
Jun 30, 2025 -1.72 Mn
Mar 31, 2025 -1.84 Mn
Mar 31, 2025 -1.84 Mn
Dec 31, 2024 -4.10 Mn
Dec 31, 2024 -4.10 Mn
Sep 30, 2024 -4.58 Mn
Sep 30, 2024 -4.58 Mn
Jun 30, 2024 -26.88 Mn
Jun 30, 2024 -26.88 Mn
Mar 31, 2024 98.43 Mn
Mar 31, 2024 98.43 Mn
Dec 31, 2023 -104.95 Mn
Dec 31, 2023 -104.95 Mn